بابەتی هەواڵی

Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel Seminar

Our faculty member Mr. Shad Adil Noori, a distinguished member of the Faculty of Pharmacy, delivered a seminar entitled "Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel" on Monday, July 21, 2025. The session provided valuable insights into the clinical implications of chemotherapy-induced hematological side effects in breast cancer patients

هەواڵ
Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel Seminar
Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel Seminar Our faculty member Mr. Shad Adil Noori, a distinguished member of the Faculty of Pharmacy, delivered a seminar entitled "Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel" on Monday, July 21, 2025. The session provided valuable insights into the clinical implications of chemotherapy-induced hematological side effects in breast cancer patients

پوختە

Our faculty member Mr. Shad Adil Noori, a distinguished member of the Faculty of Pharmacy, delivered a seminar entitled "Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel" on Monday, July 21, 2025. The session provided valuable insights into the clinical implications of chemotherapy-induced hematological side effects in breast cancer patients

Our faculty member Mr. Shad Adil Noori, a distinguished member of the Faculty of Pharmacy, delivered a seminar entitled "Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel" on Monday, July 21, 2025. The session provided valuable insights into the clinical implications of chemotherapy-induced hematological side effects in breast cancer patients

وێنەی زیاتر

Hematological Toxicity Assessment in Breast Cancer Patients Receiving Paclitaxel Seminar